Physician profile
Moiz Ehtesham
NPI 1174140313
$2,000.48
in general payments reported to CMS, 2019-2025
8 companies · $363 in 2025
The $363 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $33.33 · 2024: $1,604 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $902 · Food and Beverage: $793 · Education: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $901.81 |
| Food and Beverage | $793.48 |
| Education | $305.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,749.96 | 2024-2025 | Gallant, Thoratec Heartmate 3 Lvas Implant Kit, Ensite |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $123.50 | 2023-2024 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $42.02 | 2024 | Uptravi |
| Kestra Medical Technology Services, INC. | $19.99 | 2024 | Assure Wcd |
| Bridgebio Pharma, INC. | $19.88 | 2025 | Attruby |
| Heartflow, INC. | $18.23 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $13.53 | 2025 | Eliquis |
| Getinge USA Sales, LLC | $13.37 | 2023 | Cardiosave Hybrid, Type B Plug |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moiz Ehtesham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.